UnitedHealth Group Inc

UNH-N

NYSE:UNH

306.97
1.99 (0.65%)
UnitedHealth Group Inc. is an American for profit managed health care company based in Minnetonka, Minnesota. It is sixth in the United States on the Fortune 500.
More at Wikipedia

Analysis and Opinions about UNH-N

Signal
Opinion
Expert
HOLD
HOLD
September 19, 2017

A fine company, but his choice has been Anthem (ANTM-N). Has great admiration for this company. They are very good managers. They have the attributes that are really important from a risk/rewards standpoint in the healthcare insurance space, and that is size and scale. They have enough risk aversion that you should be safe holding this.

Show full opinionHide full opinion

A fine company, but his choice has been Anthem (ANTM-N). Has great admiration for this company. They are very good managers. They have the attributes that are really important from a risk/rewards standpoint in the healthcare insurance space, and that is size and scale. They have enough risk aversion that you should be safe holding this.

TOP PICK
TOP PICK
September 14, 2017

The dominant player in health insurance in the US. They have a pharmacy benefit manager. They are squeezing down costs and gaining business. (Analysts’ target: $214.00).

Show full opinionHide full opinion

The dominant player in health insurance in the US. They have a pharmacy benefit manager. They are squeezing down costs and gaining business. (Analysts’ target: $214.00).

PAST TOP PICK
PAST TOP PICK
July 7, 2017

(A Top Pick May 20/16. Up 46.72%.) He’s been really happy with this. This is definitely the leader in their group. Management is intent on returning capital, 50% of earnings and cash flow each year.

Show full opinionHide full opinion

(A Top Pick May 20/16. Up 46.72%.) He’s been really happy with this. This is definitely the leader in their group. Management is intent on returning capital, 50% of earnings and cash flow each year.

PAST TOP PICK
PAST TOP PICK
June 13, 2017

(A Top Pick May 20/16. Up 40%.) The whole healthcare space is at a neutral. This is the biggest Medicare/Medicaid provider in the US. They are great operators and have got scale. Great management team.

Show full opinionHide full opinion

(A Top Pick May 20/16. Up 40%.) The whole healthcare space is at a neutral. This is the biggest Medicare/Medicaid provider in the US. They are great operators and have got scale. Great management team.

TOP PICK
TOP PICK
June 13, 2017

He likes its scale. It is the leader in every single group that it does business in. It has the widest geographic dispersion for its businesses. It is driving costs down for the government spend, which they badly need. Dividend yield of 1.6%. (Analysts’ price target is $194.)

Show full opinionHide full opinion

He likes its scale. It is the leader in every single group that it does business in. It has the widest geographic dispersion for its businesses. It is driving costs down for the government spend, which they badly need. Dividend yield of 1.6%. (Analysts’ price target is $194.)

TOP PICK
TOP PICK
May 10, 2017

The largest health insurer in the US. There are strong structural tailwinds within the managed care subsector and some potential tax windfalls. They’ve been using their health scripts to win business and reduce costs. Dividend yield of 1.4%. (Analysts’ price target is $191.)

Show full opinionHide full opinion

The largest health insurer in the US. There are strong structural tailwinds within the managed care subsector and some potential tax windfalls. They’ve been using their health scripts to win business and reduce costs. Dividend yield of 1.4%. (Analysts’ price target is $191.)

PAST TOP PICK
PAST TOP PICK
April 6, 2017

(Top Pick Mar 2/17, Up 39%) There is a move toward trying to reduce the per capita health care spending. They are compressing their business and picking up a lot of CVS-N customers. It is not terribly affected either way by a policy shift. They return 50% of free cash flow to shareholders. They have government contracts behind them. It came off his list, but there is nothing wrong with them.

Show full opinionHide full opinion

(Top Pick Mar 2/17, Up 39%) There is a move toward trying to reduce the per capita health care spending. They are compressing their business and picking up a lot of CVS-N customers. It is not terribly affected either way by a policy shift. They return 50% of free cash flow to shareholders. They have government contracts behind them. It came off his list, but there is nothing wrong with them.

DON'T BUY
DON'T BUY
March 21, 2017

He is not adding to his holdings right now. The industry leader in terms of health insurance. The time when he really backed up the truck was in the early part of Mr. Obama’s administration when stocks were just begging to be picked up off the sidewalks. Since then, this company has done extremely well. For your healthcare exposure, he would be looking at the more traditional companies such as Abbott Labs, Pfizer’s, Merck’s, GlaxoSmithKline’s.

Show full opinionHide full opinion

He is not adding to his holdings right now. The industry leader in terms of health insurance. The time when he really backed up the truck was in the early part of Mr. Obama’s administration when stocks were just begging to be picked up off the sidewalks. Since then, this company has done extremely well. For your healthcare exposure, he would be looking at the more traditional companies such as Abbott Labs, Pfizer’s, Merck’s, GlaxoSmithKline’s.

PAST TOP PICK
PAST TOP PICK
February 22, 2017

(A Top Pick June 22/16. Up 17.44%.) They are the dominant medical insurer. The transition from straight Medicare to Medicare Advantage will be a positive tailwind for them. There are some tax benefits coming down the pipeline that will be positive for them. The only US medical insurer that is integrated with its pharmacy benefit manager, which is proving to be positive.

Show full opinionHide full opinion

(A Top Pick June 22/16. Up 17.44%.) They are the dominant medical insurer. The transition from straight Medicare to Medicare Advantage will be a positive tailwind for them. There are some tax benefits coming down the pipeline that will be positive for them. The only US medical insurer that is integrated with its pharmacy benefit manager, which is proving to be positive.

HOLD
HOLD
February 17, 2017

A very high quality health care provider in the US. If you want exposure there, it is one of the best companies to hold. She likes healthcare as a secular theme due to the aging demographics. There is not one specific reason why is has gone up recently. Keep holding it.

Show full opinionHide full opinion

A very high quality health care provider in the US. If you want exposure there, it is one of the best companies to hold. She likes healthcare as a secular theme due to the aging demographics. There is not one specific reason why is has gone up recently. Keep holding it.

COMMENT
COMMENT
October 14, 2016

Technically this has been doing okay, but it is currently testing its support level, and trading in a range right now. Historically, healthcare stocks at this time of year have underperformed the market. It is best not to be in the stock right now.

Show full opinionHide full opinion

Technically this has been doing okay, but it is currently testing its support level, and trading in a range right now. Historically, healthcare stocks at this time of year have underperformed the market. It is best not to be in the stock right now.

COMMENT
COMMENT
August 31, 2016

A great business, and a leader in Pharma/benefits management space. Their franchise of Optum has been eating up market share in that fragmented space. Also, have contracts with the US military. Thinks it could have a little bit of volatility if there is a Clinton president, which could give you a buying opportunity.

Show full opinionHide full opinion

A great business, and a leader in Pharma/benefits management space. Their franchise of Optum has been eating up market share in that fragmented space. Also, have contracts with the US military. Thinks it could have a little bit of volatility if there is a Clinton president, which could give you a buying opportunity.

WAIT
WAIT
August 29, 2016

It is coming in under EBV+5, or $116.81, -14% to model price. We are getting 9% compound health care cost increases in the US annually. Wait for $110, EBV+4, to buy the stock again.

Show full opinionHide full opinion

It is coming in under EBV+5, or $116.81, -14% to model price. We are getting 9% compound health care cost increases in the US annually. Wait for $110, EBV+4, to buy the stock again.

PAST TOP PICK
PAST TOP PICK
August 26, 2016

(A Top Pick Aug 27/15. Up 18.02%.) Recently took profits on this. The healthcare sector is under little pressure with some of the rhetoric coming out of the election talk in the US. He still likes this, but it might hold back a little by more talk from the US politics.

Show full opinionHide full opinion

(A Top Pick Aug 27/15. Up 18.02%.) Recently took profits on this. The healthcare sector is under little pressure with some of the rhetoric coming out of the election talk in the US. He still likes this, but it might hold back a little by more talk from the US politics.

PAST TOP PICK
PAST TOP PICK
July 19, 2016

(A Top Pick July 9/15. Up 19.48%.) He owns a number of themes in the US that are not driven by the economy. Spending in health care is rising in the US.

Show full opinionHide full opinion

(A Top Pick July 9/15. Up 19.48%.) He owns a number of themes in the US that are not driven by the economy. Spending in health care is rising in the US.

Showing 46 to 60 of 109 entries